1. Home
  2. PCSA vs OMH Comparison

PCSA vs OMH Comparison

Compare PCSA & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

N/A

Current Price

$1.89

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

N/A

Current Price

$7.46

Market Cap

4.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PCSA
OMH
Founded
2011
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.6M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
PCSA
OMH
Price
$1.89
$7.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
186.7K
★ 4.4M
Earning Date
11-17-2026
09-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $5,000.00
N/A
Revenue This Year
N/A
$39.14
Revenue Next Year
N/A
$145.74
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.11
$0.06
52 Week High
$8.88
$18.23

Technical Indicators

Market Signals
Indicator
PCSA
OMH
Relative Strength Index (RSI) 53.91 59.21
Support Level $1.80 $0.83
Resistance Level $2.03 N/A
Average True Range (ATR) 0.15 2.35
MACD 0.02 0.82
Stochastic Oscillator 57.84 30.51

Price Performance

Historical Comparison
PCSA
OMH

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.

Share on Social Networks: